NCT06579560

Brief Summary

Fibromyalgia (FM) is a common rheumatic illness distinguished by chronic pain, fatigue, cognitive problems, and functional disability. However, the differences between men and women have not yet been comprehensively studied, especially after the development of the last 2016 American College of Rheumatology (ACR) criteria. The disease is more common and more severe in female patients according to a study on gender differences among Egyptian patients (A. Moshrif et al., 2023)

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
4

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2023

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 16, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

August 12, 2024

Completed
18 days until next milestone

First Posted

Study publicly available on registry

August 30, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 16, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 16, 2025

Completed
Last Updated

August 30, 2024

Status Verified

August 1, 2024

Enrollment Period

2 years

First QC Date

August 12, 2024

Last Update Submit

August 28, 2024

Conditions

Keywords

Audiovestibular assessment, Fibromyalgia

Outcome Measures

Primary Outcomes (1)

  • Hearing Sensitivity

    Measurement of hearing sensitivity using pure tone audiometry. The outcome will be expressed as hearing thresholds in decibels (dB) at various frequencies (e.g., 250 Hz, 500 Hz, 1000 Hz, 2000 Hz, 4000 Hz). \[Unit of Measure: Decibels (dB)\]

    2 years

Interventions

Audiovestibular assessment in Patients with Fibromyalgia

Eligibility Criteria

Age15 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patients diagnosed with Fibromyalgia recruited from the Rheumatology and Rehabilitation Department at Al-Azhar University Hospital

You may qualify if:

  • Sex: Male \& Female.
  • Patients with fulfilling the criteria for the diagnosis of FM

You may not qualify if:

  • Other causes of SNHL as Meniere's disease.
  • Other causes of Conductive hearing loss (CHL) as chronic suppurative otitis media CSOM.
  • Other causes of collagen and connective tissue diseases.
  • Abnormal EMG.
  • Abnormal radiological studies of the brain.
  • Patients are receiving of ototoxic drugs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine - Assiut University

Asyut, Asyut Governorate, 71111, Egypt

RECRUITING

MeSH Terms

Conditions

Fibromyalgia

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System Diseases

Study Officials

  • Enass S. Mohamed, Professor

    Assiut University

    STUDY CHAIR
  • Abdelhafeez M. Moshrif, Professor

    Assiut University

    STUDY CHAIR
  • Mohamed A. Elmoursy, Professor

    Assiut University

    STUDY CHAIR

Central Study Contacts

Mohamed A. Ali, MA

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Dr

Study Record Dates

First Submitted

August 12, 2024

First Posted

August 30, 2024

Study Start

April 16, 2023

Primary Completion

April 16, 2025

Study Completion

April 16, 2025

Last Updated

August 30, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations